A randomized, placebo controlled, multicenter phase IIb study of human recombinant Interleukin-7 (CYT107) in HIV-related Progressive Multifocal Leukoencephalopathy

Trial Profile

A randomized, placebo controlled, multicenter phase IIb study of human recombinant Interleukin-7 (CYT107) in HIV-related Progressive Multifocal Leukoencephalopathy

Recruiting
Phase of Trial: Phase II

Latest Information Update: 20 May 2014

At a glance

  • Drugs Interleukin-7 (Primary)
  • Indications Progressive multifocal leukoencephalopathy
  • Focus Therapeutic Use
  • Acronyms INVICTUS
  • Sponsors Revimmune SAS
  • Most Recent Events

    • 02 Feb 2013 Planned end date changed from 1 Jun 2015 to 22 Jul 2015 as reported by European Clinical Trials Database record.
    • 21 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top